Skip to main content


Figure 2 | BMC Cancer

Figure 2

From: Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: Study in paraffin tissue sections

Figure 2

Representative cases of mAR positive (A) and negative (B) tumor specimens. A representative case of mAR positive (A) and a negative case (B) are shown. Left panels present H&E staining, middle panels present BSA-FITC staining, while right panels present staining with testosterone-BSA-FITC. Note the membrane localization of fluorescence in positive cells. Lower panel presents a higher magnification of the square region shown. In all cases preincubation with 3% BSA and 10-4M cyproterone acetate was performed, prior to mAR detection. Compare Figure 2 with Figure 1 (no preincubation).

Back to article page